Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

01 December 2005

The antimicrobial potential of honey from United Arab Emirates on some microbial isolates.

Noori Al-Waili, Muhammad Akmal, Faiza Al-Waili, Khelod Saloom, Amjed Ali

Med Sci Monit 2005; 11(12): BR433-438 :: ID: 438827

Abstract

Background: The study investigated activity of honey towards pathogenswhen grown in media contained honey, or when honey was added to cultures after inoculation. Material/Methods:1 -Staphylococcus aureus (S. aureus), Streptococcus pyogenes (S. pyogenes), E.coli and Candida albicans(C. albicans) were cultured into broth containing 10-100% (wt/v) honey concentrations. 2 - Honey wasadded to broth inoculated with isolates after inoculation. 3 - Optimum growth of isolates, therapeuticperiod of honey, and time after addition of honey that showed optimum effect was measured. Results: Theoptimum growth of E. Coli and C. Albicans was 10 hrs and S. aureus was 12 hrs. Honey (30-70%) preventsgrowth of all isolates. Honey (80%) inhibited growth of small (1 ul) and large size of inoculum (10 ul)of E. Coli and S. Aureus when added to their cultures during 24 hrs after inoculation. Honey inhibitedgrowth of C. Albicans when added during 2 to 6 hrs after inoculation. Honey delayed the appearance ofmicrobial growth on the plates. Reculturing of specimens collected from media that showed no growth afteraddition of honey yielded recovery growth for E.coli and C. Albicans, and therapeutic period of honeyfor E.coli and S. Aureus was 2-24 hrs and for C. Albicans was 2-6 hrs. Conclusions: Honey prevents growthof the isolates and inhibits their growth when honey was added to growing culture. The therapeutic periodof honey and recovery growth of inhibited isolates necessitates adjustment of honey doses according totype of isolate and grade of growth.

Keywords: Culture Media - pharmacology, Candida albicans - growth & development, Anti-Infective Agents - pharmacology, Escherichia coli - growth & development, Honey, Staphylococcus aureus - growth & development, Streptococcus pyogenes - growth & development, United Arab Emirates

Add Comment 0 Comments

Editorial

01 March 2024 : Editorial  

Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and Transfusion-Dependent β-Thalassemia

Dinah V. Parums

DOI: 10.12659/MSM.944204

Med Sci Monit 2024; 30:e944204

0:00

In Press

18 Mar 2024 : Clinical Research  

Sexual Dysfunction in Women After Tibial Fracture: A Retrospective Comparative Study

Med Sci Monit In Press; DOI: 10.12659/MSM.944136  

0:00

21 Feb 2024 : Clinical Research  

Potential Value of HSP90α in Prognosis of Triple-Negative Breast Cancer

Med Sci Monit In Press; DOI: 10.12659/MSM.943049  

22 Feb 2024 : Review article  

Differentiation of Native Vertebral Osteomyelitis: A Comprehensive Review of Imaging Techniques and Future ...

Med Sci Monit In Press; DOI: 10.12659/MSM.943168  

23 Feb 2024 : Clinical Research  

A Study of 60 Patients with Low Back Pain to Compare Outcomes Following Magnetotherapy, Ultrasound, Laser, ...

Med Sci Monit In Press; DOI: 10.12659/MSM.943732  

Most Viewed Current Articles

16 May 2023 : Clinical Research  

Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...

DOI :10.12659/MSM.940387

Med Sci Monit 2023; 29:e940387

0:00

17 Jan 2024 : Review article  

Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron Variant

DOI :10.12659/MSM.942799

Med Sci Monit 2024; 30:e942799

0:00

14 Dec 2022 : Clinical Research  

Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase Levels

DOI :10.12659/MSM.937990

Med Sci Monit 2022; 28:e937990

0:00

01 Jan 2022 : Editorial  

Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...

DOI :10.12659/MSM.935952

Med Sci Monit 2022; 28:e935952

0:00

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750